CT-1113

N/A

Report date: 2025/07/10 11:35:56
NME

Base Information

Drug NameCT-1113
Drug Alias NameCT-1113
ClassificationOther
Mechanisms of ActionUSP28 inhibitors
TargetsUSP28
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChaser Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChaser Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A